Global Polyvalent Streptococcus Pneumococcal Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Polyvalent Streptococcus Pneumococcal Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Polyvalent Streptococcus Pneumococcal Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Polyvalent Streptococcus Pneumococcal Vaccines Segment by Type

2.2.1 9-Valent

2.2.2 13-Valent

2.2.3 23-Valent

2.2.4 Others

2.3 Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type

2.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Type (2017-2022)

2.4 Polyvalent Streptococcus Pneumococcal Vaccines Segment by Application

2.4.1 Hospital

2.4.2 Community Clinics

2.4.3 Public Health Agencies

2.4.4 Others

2.5 Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application

2.5.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Application (2017-2022)

3 Global Polyvalent Streptococcus Pneumococcal Vaccines by Company

3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Breakdown Data by Company

3.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Company (2020-2022)

3.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Company

3.4 Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Location Distribution

3.4.2 Players Polyvalent Streptococcus Pneumococcal Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Polyvalent Streptococcus Pneumococcal Vaccines by Geographic Region

4.1 World Historic Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue by Geographic Region

4.2 World Historic Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue by Country/Region

4.3 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth

4.4 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth

4.5 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth

4.6 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth

5 Americas

5.1 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country

5.1.1 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2022)

5.1.2 Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2022)

5.2 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type

5.3 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region

6.1.1 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2017-2022)

6.1.2 APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2017-2022)

6.2 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type

6.3 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines by Country

7.1.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2022)

7.1.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2022)

7.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type

7.3 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines by Country

8.1.1 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type

8.3 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumococcal Vaccines

10.3 Manufacturing Process Analysis of Polyvalent Streptococcus Pneumococcal Vaccines

10.4 Industry Chain Structure of Polyvalent Streptococcus Pneumococcal Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors

11.3 Polyvalent Streptococcus Pneumococcal Vaccines Customer

12 World Forecast Review for Polyvalent Streptococcus Pneumococcal Vaccines by Geographic Region

12.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Forecast by Region

12.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecast by Region (2023-2028)

12.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecast by Type

12.7 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline

13.1.1 GlaxoSmithKline Company Information

13.1.2 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline Main Business Overview

13.1.5 GlaxoSmithKline Latest Developments

13.2 LG Chem

13.2.1 LG Chem Company Information

13.2.2 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.2.3 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 LG Chem Main Business Overview

13.2.5 LG Chem Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.3.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Panacea Biotec

13.4.1 Panacea Biotec Company Information

13.4.2 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.4.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Panacea Biotec Main Business Overview

13.4.5 Panacea Biotec Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.5.3 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 Pfizer

13.6.1 Pfizer Company Information

13.6.2 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.6.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Pfizer Main Business Overview

13.6.5 Pfizer Latest Developments

13.7 Shire

13.7.1 Shire Company Information

13.7.2 Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.7.3 Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Shire Main Business Overview

13.7.5 Shire Latest Developments

13.8 Pnuvax Incorporated

13.8.1 Pnuvax Incorporated Company Information

13.8.2 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pnuvax Incorporated Main Business Overview

13.8.5 Pnuvax Incorporated Latest Developments

13.9 Serum Institute

13.9.1 Serum Institute Company Information

13.9.2 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.9.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Serum Institute Main Business Overview

13.9.5 Serum Institute Latest Developments

13.10 Shinogi

13.10.1 Shinogi Company Information

13.10.2 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.10.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Shinogi Main Business Overview

13.10.5 Shinogi Latest Developments

13.11 Shenzhen Kangtai Biological Products

13.11.1 Shenzhen Kangtai Biological Products Company Information

13.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Shenzhen Kangtai Biological Products Main Business Overview

13.11.5 Shenzhen Kangtai Biological Products Latest Developments

13.12 SK Bioscience

13.12.1 SK Bioscience Company Information

13.12.2 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.12.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 SK Bioscience Main Business Overview

13.12.5 SK Bioscience Latest Developments

13.13 Walvax Biotechnology

13.13.1 Walvax Biotechnology Company Information

13.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Walvax Biotechnology Main Business Overview

13.13.5 Walvax Biotechnology Latest Developments

13.14 Eli Lilly

13.14.1 Eli Lilly Company Information

13.14.2 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.14.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Eli Lilly Main Business Overview

13.14.5 Eli Lilly Latest Developments

13.15 Abera

13.15.1 Abera Company Information

13.15.2 Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.15.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Abera Main Business Overview

13.15.5 Abera Latest Developments

13.16 Sanofi

13.16.1 Sanofi Company Information

13.16.2 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.16.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Sanofi Main Business Overview

13.16.5 Sanofi Latest Developments

13.17 Genentech

13.17.1 Genentech Company Information

13.17.2 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

13.17.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Genentech Main Business Overview

13.17.5 Genentech Latest Developments

14 Research Findings and Conclusion

Table 1. Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 9-Valent

Table 4. Major Players of 13-Valent

Table 5. Major Players of 23-Valent

Table 6. Major Players of Others

Table 7. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2022) & (K Units)

Table 8. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2017-2022)

Table 9. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2017-2022) & ($ million)

Table 10. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2017-2022)

Table 11. Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2022) & (K Units)

Table 13. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2017-2022)

Table 14. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2017-2022)

Table 15. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2017-2022)

Table 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Company (2020-2022) & (K Units)

Table 18. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Company (2020-2022)

Table 19. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Company (2020-2022)

Table 21. Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Producing Area Distribution and Sales Area

Table 23. Players Polyvalent Streptococcus Pneumococcal Vaccines Products Offered

Table 24. Polyvalent Streptococcus Pneumococcal Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share Geographic Region (2017-2022)

Table 29. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country/Region (2017-2022)

Table 33. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2022) & (K Units)

Table 36. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2017-2022)

Table 37. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2017-2022)

Table 39. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2022) & (K Units)

Table 40. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2017-2022)

Table 41. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2022) & (K Units)

Table 42. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2017-2022)

Table 43. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2017-2022) & (K Units)

Table 44. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2017-2022)

Table 45. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2017-2022)

Table 47. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2022) & (K Units)

Table 48. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2017-2022)

Table 49. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2022) & (K Units)

Table 50. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2017-2022)

Table 51. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2022) & (K Units)

Table 52. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2017-2022)

Table 53. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2017-2022)

Table 55. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2022) & (K Units)

Table 56. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2017-2022)

Table 57. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2022) & (K Units)

Table 58. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Polyvalent Streptococcus Pneumococcal Vaccines

Table 68. Key Market Challenges & Risks of Polyvalent Streptococcus Pneumococcal Vaccines

Table 69. Key Industry Trends of Polyvalent Streptococcus Pneumococcal Vaccines

Table 70. Polyvalent Streptococcus Pneumococcal Vaccines Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Polyvalent Streptococcus Pneumococcal Vaccines Distributors List

Table 73. Polyvalent Streptococcus Pneumococcal Vaccines Customer List

Table 74. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Forecast by Region

Table 76. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 94. GlaxoSmithKline Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 95. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 96. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. GlaxoSmithKline Main Business

Table 98. GlaxoSmithKline Latest Developments

Table 99. LG Chem Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 100. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 101. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. LG Chem Main Business

Table 103. LG Chem Latest Developments

Table 104. Merck Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 105. Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 106. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Merck Main Business

Table 108. Merck Latest Developments

Table 109. Panacea Biotec Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 110. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 111. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Panacea Biotec Main Business

Table 113. Panacea Biotec Latest Developments

Table 114. AstraZeneca Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 115. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 116. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. AstraZeneca Main Business

Table 118. AstraZeneca Latest Developments

Table 119. Pfizer Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 120. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 121. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Pfizer Main Business

Table 123. Pfizer Latest Developments

Table 124. Shire Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 125. Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 126. Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Shire Main Business

Table 128. Shire Latest Developments

Table 129. Pnuvax Incorporated Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 130. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 131. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Pnuvax Incorporated Main Business

Table 133. Pnuvax Incorporated Latest Developments

Table 134. Serum Institute Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 135. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 136. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Serum Institute Main Business

Table 138. Serum Institute Latest Developments

Table 139. Shinogi Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 140. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 141. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Shinogi Main Business

Table 143. Shinogi Latest Developments

Table 144. Shenzhen Kangtai Biological Products Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 145. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 146. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Shenzhen Kangtai Biological Products Main Business

Table 148. Shenzhen Kangtai Biological Products Latest Developments

Table 149. SK Bioscience Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 150. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 151. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. SK Bioscience Main Business

Table 153. SK Bioscience Latest Developments

Table 154. Walvax Biotechnology Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 155. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 156. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Walvax Biotechnology Main Business

Table 158. Walvax Biotechnology Latest Developments

Table 159. Eli Lilly Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 160. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 161. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Eli Lilly Main Business

Table 163. Eli Lilly Latest Developments

Table 164. Abera Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 165. Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 166. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Abera Main Business

Table 168. Abera Latest Developments

Table 169. Sanofi Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 170. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 171. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 172. Sanofi Main Business

Table 173. Sanofi Latest Developments

Table 174. Genentech Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 175. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Offered

Table 176. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 177. Genentech Main Business

Table 178. Genentech Latest Developments

List of Figures

Figure 1. Picture of Polyvalent Streptococcus Pneumococcal Vaccines

Figure 2. Polyvalent Streptococcus Pneumococcal Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 9-Valent

Figure 10. Product Picture of 13-Valent

Figure 11. Product Picture of 23-Valent

Figure 12. Product Picture of Others

Figure 13. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type in 2021

Figure 14. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2017-2022)

Figure 15. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Hospital

Figure 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Hospital (2017-2022) & (K Units)

Figure 17. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Community Clinics

Figure 18. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Community Clinics (2017-2022) & (K Units)

Figure 19. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Public Health Agencies

Figure 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Public Health Agencies (2017-2022) & (K Units)

Figure 21. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Others

Figure 22. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Others (2017-2022) & (K Units)

Figure 23. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2017-2022)

Figure 24. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application in 2021

Figure 25. Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Company in 2021

Figure 27. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Geographic Region in 2021

Figure 29. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2017-2022)

Figure 30. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country/Region in 2021

Figure 31. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales 2017-2022 (K Units)

Figure 32. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales 2017-2022 (K Units)

Figure 34. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales 2017-2022 (K Units)

Figure 36. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2017-2022 ($ Millions)

Figure 39. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country in 2021

Figure 40. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country in 2021

Figure 41. United States Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region in 2021

Figure 46. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Regions in 2021

Figure 47. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country in 2021

Figure 54. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country in 2021

Figure 55. Germany Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country in 2021

Figure 62. Egypt Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumococcal Vaccines in 2021

Figure 68. Manufacturing Process Analysis of Polyvalent Streptococcus Pneumococcal Vaccines

Figure 69. Industry Chain Structure of Polyvalent Streptococcus Pneumococcal Vaccines

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles